A survey of surface imaging use in radiation oncology in the United States.

J Appl Clin Med Phys 2019 Dec 19;20(12):70-77. Epub 2019 Nov 19.

Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, USA.

Surface imaging (SI) has been rapidly integrated into radiotherapy clinics across the country without specific guidelines and recommendations on its commissioning and use aside from vendor-provided information. A survey was created under the auspices of AAPM TG-302 to assess the current status of SI to identify if there is need for formal guidance. The survey was designed to determine the institutional setting of responders, availability and length of its use, commissioning procedures, and clinical applications. This survey was created in REDCap, and approved as IRB exempt to collect anonymized data. Questions were reviewed by multiple physicists to ensure concept validity and piloted by a small group of independent physicists to ensure process validity. All full members of AAPM self-identified as "therapy" or "other" were sent the survey link by email. The survey was active from February to March 2018. Of 3677 members successfully contacted, 439 completed responses; the summary of these responses provides insight on current surface imaging clinical practices, though they should not be assumed to be representative of radiation oncology as a whole. Results showed that 53.3% of respondents have SI in their clinics, mostly in treatment rooms, rarely in simulation rooms. Half of those without SI plan on purchasing it within 3 years. Over 10% have SI but do not use it clinically, 36.8% classify themselves as "expert" users, and 85.5% agreed/strongly agreed that SI guidelines are needed. Initial positioning with SI is most common for breast/chestwall and SRS/SBRT treatments, least common for pediatrics. Use of SI for intra-fraction monitoring follows a similar distribution. Gating with SI is most prevalent for breast/chestwall (66.0%) but also used in SBRT (33.0%), and non-SBRT lung/abdomen (<30%) treatments. SI is a rapidly growing technology in the field with widespread use for several anatomic sites. Guidelines and recommendations on commissioning and clinical use are warranted.

Download full-text PDF

Source
http://dx.doi.org/10.1002/acm2.12762DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909172PMC
December 2019

Publication Analysis

Top Keywords

surface imaging
12
radiation oncology
8
physicists ensure
8
survey created
8
survey
6
agreed/strongly agreed
4
validity full
4
855% agreed/strongly
4
process validity
4
ensure process
4
full members
4
group independent
4
independent physicists
4
aapm self-identified
4
"other" survey
4
survey link
4
"expert" users
4
"therapy" "other"
4
users 855%
4
small group
4

Altmetric Statistics

Similar Publications